Charles DeBattista

Psychiatrist

Outpatient Psychiatry Clinic

  • 401 Quarry Road
  • Stanford, CA 94304
  • Phone: 650-498-9111
Learn More About the Clinic Getting Here Make An Appointment

Professional Education

Residency: Stanford University Medical Center (1993) CA

Internship: Stanford University Medical Center (1990) CA

Board Certification: Psychiatry, American Board of Psychiatry and Neurology (1995)

Fellowship: Stanford University Medical Center (1993) CA

Medical Education: UCSF School of Medicine (1989) CA

DMH, UCSF/UC Berkeley, Mental Health (1986)

MD, UCSF, Medicine (1989)

Honors & Awards

America's Best Doctors; Psychiatry, Best Doctors (2009-2010)

Review Article of the Year, Primary Psychiatry (2004)

Teacher of the Year, Dept. Of Psychiatry (1998, 2000, 2001)

Clinical Trials

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Hospital & Clinics patient, you have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

Measuring severe adverse events and medication selection using a "PEER Report" for nonpsychotic patients: a retrospective chart review
Hoffman, D. A., DeBattista, C., Valuck, R. J., & Iosifescu, D. V. (2012). Measuring severe adverse events and medication selection using a "PEER Report" for nonpsychotic patients: a retrospective chart review. NEUROPSYCHIATRIC DISEASE AND TREATMENT, 8, 277-284.

The use of referenced-EEG (rEEG) in assisting medication selection for the treatment of depression
DeBattista, C., Kinrys, G., Hoffman, D., Goldstein, C., Zajecka, J., & Fava, M. (2011). The use of referenced-EEG (rEEG) in assisting medication selection for the treatment of depression. JOURNAL OF PSYCHIATRIC RESEARCH, 45(1), 64-75.

Safety considerations of the use of second generation antipsychotics in the treatment of major depression: extrapyramidal and metabolic side effects.
DeBattista, C., & Debattista, K. (2010). Safety considerations of the use of second generation antipsychotics in the treatment of major depression: extrapyramidal and metabolic side effects. Current drug safety, 5(3), 263-266.

Effects of major depression diagnosis and cortisol levels on indices of neurocognitive function
Gomez, R. G., Posener, J. A., Keller, J., DeBattista, C., Solvason, B., & Schatzberg, A. F. (2009). Effects of major depression diagnosis and cortisol levels on indices of neurocognitive function. PSYCHONEUROENDOCRINOLOGY, 34(7), 1012-1018.

A multisite trial of mifepristone for the treatment of psychotic depression: A site-by-treatment interaction
Blasey, C. M., DeBattista, C., Roe, R., Block, T., & Belanoff, J. K. (2009). A multisite trial of mifepristone for the treatment of psychotic depression: A site-by-treatment interaction. CONTEMPORARY CLINICAL TRIALS, 30(4), 284-288.

Utility of Atypical Antipsychotics in the Treatment of Resistant Unipolar Depression
DeBattista, C., & Hawkins, J. (2009). Utility of Atypical Antipsychotics in the Treatment of Resistant Unipolar Depression. CNS DRUGS, 23(5), 369-377.

Sildenafil treatment of women with antidepressant-associated sexual dysfunction - A randomized controlled trial
Nurnberg, H. G., Hensley, P. L., Heiman, J. R., Croft, H. A., DeBattista, C., & Paine, S. (2008). Sildenafil treatment of women with antidepressant-associated sexual dysfunction - A randomized controlled trial. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 300(4), 395-404.

Depression and smoking cessation: does the evidence support psychiatric practice?
Lembke, A., Johnson, K., & DeBattista, C. (2007). Depression and smoking cessation: does the evidence support psychiatric practice?. Neuropsychiatric disease and treatment, 3(4), 487-493.

Modafinil augmentation of selective serotonin reuptake inhibitor therapy in MDD partial responders with persistent fatigue and sleepiness.
Fava, M., Thase, M. E., DeBattista, C., Doghramji, K., Arora, S., & Hughes, R. J. (2007). Modafinil augmentation of selective serotonin reuptake inhibitor therapy in MDD partial responders with persistent fatigue and sleepiness. Annals of clinical psychiatry , 19(3), 153-159.

Mifepristone versus placebo in the treatment of psychosis in patients with psychotic major depression
DeBattista, C., Belanoff, J., Glass, S., Khan, A., Horne, R. L., & Alva, G. (2006). Mifepristone versus placebo in the treatment of psychosis in patients with psychotic major depression. BIOLOGICAL PSYCHIATRY, 60(12), 1343-1349.

The neuropsychological profile of psychotic major depression and its relation to cortisol
Gomez, R. G., Fleming, S. H., Keller, J., Flores, B., Kenna, H., & Schatzberg, A. F. (2006). The neuropsychological profile of psychotic major depression and its relation to cortisol. BIOLOGICAL PSYCHIATRY, 60(5), 472-478.

The efficacy of mifepristone in the reduction and prevention of olanzapine-induced weight gain in rats
Beebe, K. L., Block, T., DeBattista, C., Blasey, C., & Belanoff, J. K. (2006). The efficacy of mifepristone in the reduction and prevention of olanzapine-induced weight gain in rats. BEHAVIOURAL BRAIN RESEARCH, 171(2), 225-229.

Augmentation and combination strategies for depression
DeBattista, C. (2006). Augmentation and combination strategies for depression. JOURNAL OF PSYCHOPHARMACOLOGY, 20(3), 11-18.

The use of mifepristone in the treatment of neuropsychiatric disorders
DeBattista, C., & Belanoff, J. (2006). The use of mifepristone in the treatment of neuropsychiatric disorders. TRENDS IN ENDOCRINOLOGY AND METABOLISM, 17(3), 117-121.

Modafinil augmentation of SSRI therapy in patients with major depressive disorder and excessive sleepiness and fatigue: A 12-week, open-label, extension study
Thase, M. E., Fava, M., Debattista, C., Arora, S., & Hughes, R. J. (2006). Modafinil augmentation of SSRI therapy in patients with major depressive disorder and excessive sleepiness and fatigue: A 12-week, open-label, extension study. CNS SPECTRUMS, 11(2), 93-102.

Detecting psychotic major depression using psychiatric rating scales
Keller, J., Gomez, R. G., Kenna, H. A., Poesner, J., Debattista, C., & Schatzberg, A. F. (2006). Detecting psychotic major depression using psychiatric rating scales. JOURNAL OF PSYCHIATRIC RESEARCH, 40(1), 22-29.

Update on augmentation of antidepressant response in resistant depression.
DeBattista, C., & Lembke, A. (2005). Update on augmentation of antidepressant response in resistant depression. Current psychiatry reports, 7(6), 435-440.

The efficacy of divalproex sodium in the treatment of agitation associated with major depression
Debattista, C., Solomon, A., Arnow, B., Kendrick, E., Tilston, J., & Schatzberg, A. F. (2005). The efficacy of divalproex sodium in the treatment of agitation associated with major depression. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 25(5), 476-479.

A placebo-controlled, randomized, double-blind study of adjunctive bupropion sustained release in the treatment of SSRI-induced sexual dysfunction
DeBattista, C., Solvason, B., Poirier, J., Kendrick, E., & Loraas, E. (2005). A placebo-controlled, randomized, double-blind study of adjunctive bupropion sustained release in the treatment of SSRI-induced sexual dysfunction. JOURNAL OF CLINICAL PSYCHIATRY, 66(7), 844-848.

C-1073 (mifepristone) in the adjunctive treatment of Alzheimer's disease.
DeBattista, C., & Belanoff, J. (2005). C-1073 (mifepristone) in the adjunctive treatment of Alzheimer's disease. Current Alzheimer research, 2(2), 125-129.

Executive dysfunction in major depressive disorder.
DeBattista, C. (2005). Executive dysfunction in major depressive disorder. Expert review of neurotherapeutics, 5(1), 79-83.

A multicenter, placebo-controlled study of modafinil augmentation in partial responders to selective serotonin reuptake inhibitors with persistent fatigue and sleepiness
Fava, M., Thase, M. E., & Debattista, C. (2005). A multicenter, placebo-controlled study of modafinil augmentation in partial responders to selective serotonin reuptake inhibitors with persistent fatigue and sleepiness. JOURNAL OF CLINICAL PSYCHIATRY, 66(1), 85-93.

HPA axis activation in major depression and response to fluoxetine: a pilot study
Young, E. A., Altemus, M., Lopez, J. F., Kocsis, J. H., Schatzberg, A. F., & Zubieta, J. K. (2004). HPA axis activation in major depression and response to fluoxetine: a pilot study. PSYCHONEUROENDOCRINOLOGY, 29(9), 1198-1204.

A prospective trial of modafinil as an adjunctive treatment of major depression
DeBattista, C., Lembke, A., Solvason, H. B., Ghebremichael, R., & Poirier, J. (2004). A prospective trial of modafinil as an adjunctive treatment of major depression. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 24(1), 87-90.

Seizure duration with remifentanil/methohexital vs. methohexital alone in middle-aged patients undergoing electroconvulsive therapy
Smith, D. L., Angst, M. S., Brock-Utne, J. G., & Debattista, C. (2003). Seizure duration with remifentanil/methohexital vs. methohexital alone in middle-aged patients undergoing electroconvulsive therapy. ACTA ANAESTHESIOLOGICA SCANDINAVICA, 47(9), 1064-1066.

Adjunct modafinil for the short-term treatment of fatigue and sleepiness in patients with major depressive disorder: A preliminary double-blind, placebo-controlled study
Debattista, C., Doghramji, K., Menza, M. A., Rosenthal, M. H., & Fieve, R. R. (2003). Adjunct modafinil for the short-term treatment of fatigue and sleepiness in patients with major depressive disorder: A preliminary double-blind, placebo-controlled study. JOURNAL OF CLINICAL PSYCHIATRY, 64(9), 1057-1064.

Safety of antidepressants in the elderly.
Sommer, B. R., Fenn, H., Pompei, P., DeBattista, C., Lembke, A., & Flores, B. (2003). Safety of antidepressants in the elderly. Expert opinion on drug safety, 2(4), 367-383.

A prospective trial of bupropion SR augmentation of partial and non-responders to Serotonergic antidepressants
Debattista, C., Solvason, H. B., Poirier, J., Kendrick, E., & Schatzberg, A. F. (2003). A prospective trial of bupropion SR augmentation of partial and non-responders to Serotonergic antidepressants. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 23(1), 27-30.

The timing of electroconvulsive therapy and bispectral index after anesthesia induction using different drugs does not affect seizure duration
Lemmens, H. Jm., Levi, D. C., Debattista, C., & Brock-Utne, J. G. (2003). The timing of electroconvulsive therapy and bispectral index after anesthesia induction using different drugs does not affect seizure duration. JOURNAL OF CLINICAL ANESTHESIA, 15(1), 29-32.

Fetal heart rate decelerations during ECT-induced seizures: is it important?
Debattista, C., Cochran, M., Barry, J. J., & Brock-Utne, J. G. (2003). Fetal heart rate decelerations during ECT-induced seizures: is it important?. ACTA ANAESTHESIOLOGICA SCANDINAVICA, 47(1), 101-103.

An open label trial of C-1073 (mifepristone) for psychotic major depression
Belanoff, J. K., Rothschild, A. J., Cassidy, F., Debattista, C., Baulieu, E. E., & Schatzberg, A. F. (2002). An open label trial of C-1073 (mifepristone) for psychotic major depression. BIOLOGICAL PSYCHIATRY, 52(5), 386-392.

Slowing the progression of cognitive decline in Alzheimer's disease using mifepristone
Belanoff, J. K., Jurik, J., Schatzberg, L. D., Debattista, C., & Schatzberg, A. F. (2002). Slowing the progression of cognitive decline in Alzheimer's disease using mifepristone. JOURNAL OF MOLECULAR NEUROSCIENCE, 19(1-2), 201-206.

Cortisol feedback during the HPA quiescent period in patients with major depression
Posener, J. A., Debattista, C., Williams, G. H., & Schatzberg, A. F. (2001). Cortisol feedback during the HPA quiescent period in patients with major depression. AMERICAN JOURNAL OF PSYCHIATRY, 158(12), 2083-2085.

Is electroconvulsive therapy effective for the depressed patient with comorbid borderline personality disorder?
Debattista, C., & Mueller, K. (2001). Is electroconvulsive therapy effective for the depressed patient with comorbid borderline personality disorder?. JOURNAL OF ECT, 17(2), 91-98.

Sertraline versus imipramine to prevent relapse in chronic depression
Koran, L. M., Gelenberg, A. J., Kornstein, S. G., Howland, R. H., Friedman, R. A., & Keller, M. B. (2001). Sertraline versus imipramine to prevent relapse in chronic depression. JOURNAL OF AFFECTIVE DISORDERS, 65(1), 27-36.

Psychopharmacologic treatment strategies for depression, bipolar disorder, and schizophrenia
Glick, I. D., Suppes, T., Debattista, C., Hu, R. J., & Marder, S. (2001). Psychopharmacologic treatment strategies for depression, bipolar disorder, and schizophrenia. ANNALS OF INTERNAL MEDICINE, 134(1), 47-60.

Acute antidepressant effects of intravenous hydrocortisone and CRH in depressed patients: A double-blind, placebo-controlled study
Debattista, C., Posener, J. A., Kalehzan, B. M., & Schatzberg, A. F. (2000). Acute antidepressant effects of intravenous hydrocortisone and CRH in depressed patients: A double-blind, placebo-controlled study. AMERICAN JOURNAL OF PSYCHIATRY, 157(8), 1334-1337.

24-hour monitoring of cortisol and corticotropin secretion in psychotic and nonpsychotic major depression
Posener, J. A., Debattista, C., Williams, G. H., Kraemer, H. C., Kalehzan, B. M., & Schatzberg, A. F. (2000). 24-hour monitoring of cortisol and corticotropin secretion in psychotic and nonpsychotic major depression. ARCHIVES OF GENERAL PSYCHIATRY, 57(8), 755-760.

Neuropsychological deficits in psychotic versus nonpsychotic major depression and no mental illness
Schatzberg, A. F., Posener, J. A., Debattista, C., Kalehzan, B. M., Rothschild, A. J., & Shear, P. K. (2000). Neuropsychological deficits in psychotic versus nonpsychotic major depression and no mental illness. AMERICAN JOURNAL OF PSYCHIATRY, 157(7), 1095-1100.

Pramipexole augmentation of a selective serotonin reuptake inhibitor in the treatment of depression
Debattista, C., Solvason, H. B., Breen, J. Ah., & Schatzberg, A. F. (2000). Pramipexole augmentation of a selective serotonin reuptake inhibitor in the treatment of depression. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 20(2), 274-275.

Negative-pressure pulmonary edema: A potential mazard in patients undergoing ECT
Cochran, M., Debattista, C., Schmiesing, C., & Brock-Utne, J. G. (1999). Negative-pressure pulmonary edema: A potential mazard in patients undergoing ECT. JOURNAL OF ECT, 15(2), 168-170.

The Texas Medication Algorithm Project: Report of the Texas Consensus Conference Panel on medication treatment of major depressive disorder
Crismon, M. L., Trivedi, M., Pigott, T. A., Rush, A. J., Hirschfeld, R. Ma., & Thase, M. E. (1999). The Texas Medication Algorithm Project: Report of the Texas Consensus Conference Panel on medication treatment of major depressive disorder. JOURNAL OF CLINICAL PSYCHIATRY, 60(3), 142-156.

Phenomenology and treatment of agitation
Schatzberg, A. F., & Debattista, C. (1999). Phenomenology and treatment of agitation. JOURNAL OF CLINICAL PSYCHIATRY, 60, 17-20.

ECT in dissociative identity disorder and comorbid depression
Debattista, C., Solvason, H. B., & Spiegel, D. (1998). ECT in dissociative identity disorder and comorbid depression. JOURNAL OF ECT, 14(4), 275-279.

Serotonergic synergism: The risks and benefits of combining the selective serotonin reuptake inhibitors with other serotonergic drugs
Debattista, C., Sofuoglu, M., & Schatzberg, A. F. (1998). Serotonergic synergism: The risks and benefits of combining the selective serotonin reuptake inhibitors with other serotonergic drugs. BIOLOGICAL PSYCHIATRY, 44(5), 341-347.

Developing treatment algorithms for unipolar depression in cyberspace: International Psychopharmacology Algorithm Project (IPAP)
Trivedi, M. H., Debattista, C., Fawcett, J., Nelson, C., Osser, D. N., & Jobson, K. (1998). Developing treatment algorithms for unipolar depression in cyberspace: International Psychopharmacology Algorithm Project (IPAP). PSYCHOPHARMACOLOGY BULLETIN, 34(3), 355-359.

Treatment of psychotic depression
Debattista, C., Solvason, H. B., Belanoff, J., & Schatzberg, A. (1997). Treatment of psychotic depression. AMERICAN JOURNAL OF PSYCHIATRY, 154(11), 1625-1626.

Development of obsessive symptoms during nefazodone treatment
Sofuoglu, M., & Debattista, C. (1996). Development of obsessive symptoms during nefazodone treatment. AMERICAN JOURNAL OF PSYCHIATRY, 153(4), 577-578.

SUMATRIPTAN PROPHYLAXIS FOR POSTELECTROCONVULSIVE THERAPY HEADACHES
Debattista, C., & Mueller, K. (1995). SUMATRIPTAN PROPHYLAXIS FOR POSTELECTROCONVULSIVE THERAPY HEADACHES. HEADACHE, 35(8), 502-503.

PHYSICAL SYMPTOMS ASSOCIATED WITH PAROXETINE WITHDRAWAL
Debattista, C., & Schatzberg, A. F. (1995). PHYSICAL SYMPTOMS ASSOCIATED WITH PAROXETINE WITHDRAWAL. AMERICAN JOURNAL OF PSYCHIATRY, 152(8), 1235-1236.